Oregon, the first state to legalize psilocybin therapy services, continues to roll out the foundations of its new psychedelic medicine industry. Back in...
Though psychedelics are gaining mainstream support from media and patients alike, the medical institution is not as quick to voice its unwavering support....
Psychedelic drug company Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the first quarter of 2023 and gave an update on recent...
Psychedelic biotech company GH Research PLC (Nasdaq: GHRS) reported financial results for the first quarter that ended March 31, 2023. The company has...
Natural products include probiotics, herbal remedies, vitamins and minerals, homeopathic medicines, traditional medicines among others The post Optimi...
VANCOUVER – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), an end-to-end drug researcher and formulator licensed by Health Canada to produce...
The article Cybin Doses Last Patient in Part B of Phase 1 DMT Trial was originally published on Microdose. Cybin moves its DMT program forward as...
MindBio clinical trial published in Peer Reviewed Paper Biological Psychiatry First of 8 significant publications on LSD-Microdosing from a Phase 1 clinical...
The Church of Psilomethoxin now admits that its claims about psilomethoxin are solely based on faith. But how strong are the religious convictions of the...
DLX-001 is a non-hallucinogenic compound intended to treat various mental health conditions The post Delix Therapeutics to start clinical trial on novel...